• 1
    American Cancer Society. Cancer Facts & Figures 2012. Atlanta, GA: American Cancer Society; 2012.
  • 2
    American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society; 2012.
  • 3
    Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, (eds). SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, 2012,
  • 4
    Bernstein JL, Thompson WD, Risch N, Holford TR. Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol. 1992;136:925936.
  • 5
    Broet P, de la Rochefordiere A, Scholl SM, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol. 1995;13:15781583.
  • 6
    Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935–82. Natl Cancer Inst Monogr. 1985;68:99112.
  • 7
    Rubino C, Arriagada R, Delaloge S, Le MG. Relation of risk of contralateral breast cancer to the interval since the first primary tumor. Br J Cancer. 2010;102:213219.
  • 8
    Soerjomataram I, Louwman WJ, Lemmens VE, de Vries E, Klokman WJ, Coebergh JW. Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972–2001. Eur J Cancer. 2005;41:23312337.
  • 9
    Altekruse SF, Kosary CL, Krapcho M, et al, eds. Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review, 1975–2007. Bethesda, MD: National Cancer Institute; 2010., based on November 2009 SEER data submission, posted to the SEER Web site, 2010.
  • 10
    Cady B, Michaelson JS, Chung MA. The “tipping point” for breast cancer mortality decline has resulted from size reductions due to mammographic screening. Ann Surg Oncol. 2011;18:903906.
  • 11
    Khatcheressian JL, Wolff AC, Smith TJ, et al; American Society of Clinical Oncology. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:50915097.
  • 12
    Carcaise-Edinboro P, Bradley CJ, Dahman B. Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv. 2010;4:5966.
  • 13
    Doubeni CA, Field TS, Ulcickas Yood M, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:24822488.
  • 14
    Field TS, Doubeni C, Fox MP, et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23:158163.
  • 15
    Geller BM, Kerlikowske K, Carney PA, et al. Mammography surveillance following breast cancer. Breast Cancer Res Treat. 2003;81:107115.
  • 16
    Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:8594.
  • 17
    Mandelblatt JS, Lawrence WF, Cullen J, et al. Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol. 2006;24:7784.
  • 18
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373383.
  • 19
    Sabatino SA, Thompson TD, Richardson LC, Milller J. Health insurance and other factors associated with mammography surveillance among breast cancer survivors: results from a national survey. Med Care. 2012;50:270276.
  • 20
    Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:748757.
  • 21
    Njai R, Siegel PZ, Miller JW, Liao Y. Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995–2006. Prev Chronic Dis. 2011;8:A59.
  • 22
    Pourat N, Kagawa-Singer M, Breen N, Sripipatana A. Access versus acculturation: identifying modifiable factors to promote cancer screening among Asian American women. Med Care. 2010;48:10881096.
  • 23
    Schueler KM, Chu PW, Smith-Bindman R. Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt). 2008;17:14771498.
  • 24
    Moy B, Park ER, Feibelman S, Chiang S, Weissman JS. Barriers to repeat mammography: cultural perspectives of African American, Asian, and Hispanic women. Psychooncology. 2006;15:623634.
  • 25
    Han HS, Reis IM, Zhao W, et al. Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. Eur J Cancer. 2011;47:25372545.
  • 26
    Hollowell K, Olmsted CL, Richardson AS, et al. American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer. 2010;116:20902098.